Abstract: The invention relates to heterocyclylamide-substituted thiazoles, pyrroles and thiophenes and processes for their preparation, to pharmaceutical compositions containing them, and to their use for the treatment and/or prophylaxis of diseases, in particular for the use as antiviral agents, especially against cytomegaloviruses.
Type:
Grant
Filed:
July 1, 2006
Date of Patent:
April 2, 2013
Assignee:
AiCuris GmbH & Co. KG
Inventors:
Holger Zimmermann, David Brueckner, Kerstin Henninger, Martin Hendrix, Martin Radtke
Abstract: The present invention relates to solid dispersions comprising a compound of formula or a salt, a solvate or a solvate of a salt thereof, dispersed in a polymeric, inert, non-toxic, pharmaceutically acceptable excipient.
Type:
Application
Filed:
March 9, 2012
Publication date:
March 21, 2013
Applicant:
AiCuris GmbH & Co. KG
Inventors:
Ellen VERHOEVEN, Jody Voorspoels, Yves Gonnissen, Yves Ruysschaert
Abstract: The present invention relates to novel substituted (pyrazolylcarbonyl)imidazolidinones, methods for their preparation, their use for the treatment and/or prophylaxis of diseases, as well as their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, especially of retroviral diseases, in humans and/or animals.
Type:
Grant
Filed:
September 17, 2010
Date of Patent:
March 19, 2013
Assignee:
AiCuris GmbH & Co. KG
Inventors:
Kai Thede, Susanne Greschat, Steffen Wildum, Daniela Paulsen
Abstract: The present invention relates to novel substituted furancarboxamides, methods for their production, their use for the treatment and/or prevention of diseases, as well as their use for the production of medicaments for the treatment and/or prophylaxis of diseases, especially retroviral diseases, in humans and/or animals.
Abstract: The present invention relates to a process for the preparation of dihydroquinazolines, for example, methyl (S)-{8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoro -methyl)-phenyl]-3,4-dihydroquinazolin-4-yl}acetate (2S,3S)-2,3-bis[(4-methylbenzoyl) -oxy]succinic acid salt, which are used for the production of antiviral medicaments.
Type:
Grant
Filed:
November 30, 2011
Date of Patent:
February 12, 2013
Assignee:
AiCuris GmbH & Co. KG
Inventors:
Käthe Gooβen, Oliver Kuhn, Mathias Berwe, Joachim Kruger, Hans-Christian Militzer
Abstract: The invention relates to polynucleotides coding for the PPVO viral genome, to fragments of the polynucleotides coding for the PPVO genome and to polynucleotides coding for individual open reading frames (ORFs) of the PPVO viral genome. The invention also relates to recombinant proteins expressed from the above mentioned polynucleotides and to fragments of said recombinant proteins, and to the use of said recombinant proteins or fragments for the preparation of pharmaceutical compositions.
Type:
Grant
Filed:
June 12, 2002
Date of Patent:
January 22, 2013
Assignee:
Aicuris GmbH & Co. KG
Inventors:
Olaf Weber, Sonja Maria Friederichs, Angela Siegling, Tobias Schlapp, Andrew Allan Mercer, Stephen Bruce Fleming, Hans-Dieter Volk
Abstract: The invention relates to heterocyclyl-substituted dihydroquinazolines of formula (I), to processes for their preparation, to medicaments containing them, and to methods for the treatment and/or prophylaxis of diseases, in particular, for use as anti-viral agents, in particular, against cytomegaloviruses.
Type:
Grant
Filed:
April 28, 2004
Date of Patent:
January 1, 2013
Assignee:
AiCuris GmbH & Co. KG
Inventors:
Tobias Wunberg, Judith Baumeister, Mario Jeske, Peter Nell, Susanne Nikolic, Frank Suessmeier, Holger Zimmermann, Rolf Grosser, Kerstin Henninger, Guy Hewlett, Joerg Keldenich, Dieter Lang
Abstract: The present invention relates to the use of Parapoxviruses in combination with other agents for the treatment of viral diseases, and in particular HIV infections and AIDS. The invention also relates to methods for producing medicaments based on combinations of Parapoxviruses and other antiviral agents, and to such medicaments. In particular, the invention relates to the use of Parapoxviruses in combination with agents of the kind used for antiretroviral therapy and highly active antiretroviral therapy (HAART).
Type:
Grant
Filed:
January 11, 2007
Date of Patent:
January 1, 2013
Assignee:
AiCuris GmbH & Co. KG
Inventors:
Daniela Paulsen, Helga Ruebsamen-Schaeff, Amar Kureishi, Gerhard Hunsmann, Christiane Stahl-Hennig, Andreas Meyerhans, Alexandra Schuetz, Olaf Weber
Abstract: The present invention relates to novel substituted furancarboxamides, methods for their production, their use for the treatment and/or prevention of diseases, as well as their use for the production of medicaments for the treatment and/or prophylaxis of diseases, especially retroviral diseases, in humans and/or animals.
Type:
Grant
Filed:
June 16, 2011
Date of Patent:
December 4, 2012
Assignee:
AiCuris GmbH & Co. KG
Inventors:
Kai Thede, Susanne Greschat, Steffen Wildum, Daniela Paulsen
Abstract: The invention relates to substituted arylsulfonamides of formula (I) and methods for their preparation as well as their use for the production of medicaments for the treatment and/or prophylaxis of diseases, especially for use as antiviral agents, particularly against cytomegaloviruses.
Type:
Grant
Filed:
September 3, 2008
Date of Patent:
November 27, 2012
Assignee:
Aicuris GmbH & Co. KG
Inventors:
Niels Svenstrup, Holger Zimmermann, Dagmar Karthaus, Andreas Goeller, Dirk Heimbach, Kerstin Henninger, Dieter Lang, Daniela Paulsen, Bernd Riedl, Rudolf Schohe-Loop, Joachim Schuhmacher, Tobias Wunberg
Abstract: The present invention relates to novel substituted pyrazolamides, methods for their preparation, their use for the treatment and/or prophylaxis of diseases, as well as their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, especially of retroviral diseases, in humans and/or animals.
Type:
Grant
Filed:
September 16, 2010
Date of Patent:
November 20, 2012
Assignee:
AiCuris GmbH & Co. KG
Inventors:
Rudolf Schohe-Loop, Reinhold Welker, Arnold Paessens, Marcus Bauser, Friederike Stoll, Frank Dittmer, Kerstin Henninger, Daniela Paulsen, Dieter Lang
Abstract: The invention relates to substituted dihydroquinazolines and to a method for the production thereof, the use thereof for treating and/or preventing diseases and for producing drugs for treating and/or preventing diseases, in particular for the use of the inventive dihydroquinazolines in the form of antiviral agents, in particular against cytomegaloviruses.
Type:
Grant
Filed:
October 28, 2004
Date of Patent:
November 20, 2012
Assignee:
Aicuris GmbH & Co. KG
Inventors:
Tobias Wunberg, Judith Baumeister, Mario Jeske, Peter Nell, Susanne Nikolic, Frank Suessmeier, Holger Zimmermann, Rolf Grosser, Guy Hewlett, Jorg Keldenich, Dieter Lang, Kerstin Henninger
Abstract: This invention relates to substituted azaquinazolines, to a process for their preparation, to pharmaceutical compositions containing them, and to their use for the treatment and/or prophylaxis of diseases, especially for use as antiviral agents, in particular against cytomegaloviruses.
Type:
Grant
Filed:
December 24, 2009
Date of Patent:
June 12, 2012
Assignee:
Aicuris GmbH & Co. KG
Inventors:
Tobias Wunberg, Judith Baumeister, Mario Jeske, Frank Suessmeier, Holger Zimmermann, Kerstin Henninger, Dieter Lang
Abstract: The present invention relates to novel substituted (thiophenyl-carbonyl)imidazolidinones, methods for their production, their use for the treatment and/or prevention of diseases, as well as their use for the production of medicaments for the treatment and/or prophylaxis of diseases, especially retroviral diseases, in humans and/or animals.
Type:
Application
Filed:
June 16, 2011
Publication date:
January 26, 2012
Applicant:
AiCuris GmbH & Co. KG
Inventors:
Kai THEDE, Susanne GRESCHAT, Steffen WILDUM, Daniela PAULSEN
Abstract: The present invention relates to novel substituted furancarboxamides, methods for their production, their use for the treatment and/or prevention of diseases, as well as their use for the production of medicaments for the treatment and/or prophylaxis of diseases, especially retroviral diseases, in humans and/or animals.
Type:
Application
Filed:
June 16, 2011
Publication date:
January 26, 2012
Applicant:
AiCuris GmbH & Co. KG
Inventors:
Kai THEDE, Susanne Greschat, Steffen Wildum, Daniela Paulsen
Abstract: The present invention relates to a process for the preparation of dihydroquinazolines, for example {8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-3,4-dihydroquinazolin-4-yl}acetic acid, which are used as antiviral agents in the production of medicaments.
Type:
Grant
Filed:
June 2, 2006
Date of Patent:
December 27, 2011
Assignee:
Aicuris GmbH & Co., KG
Inventors:
Käthe Gooβen, Oliver Kuhn, Mathias Berwe, Joachim Krüger, Hans-Christian Militzer
Abstract: The invention relates to lysobactin amides and methods for their preparation, as well as their use for manufacturing medicaments for the treatment and/or prophylaxis of diseases, in particular bacterial infectious diseases.
Type:
Grant
Filed:
October 10, 2008
Date of Patent:
December 13, 2011
Assignee:
Aicuris GmbH & Co. KG
Inventors:
Franz Von Nussbaum, Hartmut Beck, Nina Brunner, Rainer Endermann, Johannes Koebberling, Jacques Ragot, Joachim Telser, Joachim Schuhmacher, Sonja Anlauf, Yolanda Cancho-Grande, Susanne Greschat, Hans-Christian Militzer, Guido Schiffer
Abstract: The present invention relates to novel substituted pyrazolamides, methods for their preparation, their use for the treatment and/or prophylaxis of diseases, as well as their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, especially of retroviral diseases, in humans and/or animals.
Type:
Application
Filed:
September 16, 2010
Publication date:
July 14, 2011
Applicant:
AiCuris Gmbh & Co. KG
Inventors:
Rudolf SCHOHE-LOOP, Reinhold Welker, Arnold Paessens, Marcus Bauser, Friederike Stoll, Frank Dittmer, Kerstin Henninger, Daniela Paulsen, Dieter Lang
Abstract: The invention relates to substituted quinolones and to methods for their preparation as well as to their use for the production of medicaments for the treatment and/or prophylaxis of diseases, especially for use as antiviral agents, particularly against cytomegaloviruses.
Type:
Grant
Filed:
August 8, 2008
Date of Patent:
July 12, 2011
Assignee:
Aicuris GmbH & Co. KG
Inventors:
Chantal Fuerstner, Kai Thede, Holger Zimmermann, David Brueckner, Kerstin Henninger, Dieter Lang, Rudolf Schohe-Loop